John Hart to Adenocarcinoma
This is a "connection" page, showing publications John Hart has written about Adenocarcinoma.
Connection Strength
1.668
-
Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas. Hum Pathol. 2020 03; 97:103-111.
Score: 0.431
-
Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer. 2002 Oct 01; 101(4):301-10.
Score: 0.131
-
Expression of Jun family members in human colorectal adenocarcinoma. Carcinogenesis. 2000 Jul; 21(7):1313-7.
Score: 0.112
-
Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers. Hum Pathol. 2019 07; 89:44-50.
Score: 0.104
-
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. Inflamm Bowel Dis. 2016 Mar; 22(3):631-7.
Score: 0.083
-
Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2016 Jul; 84(1):87-95.e1.
Score: 0.082
-
A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy. 2013 Dec; 45(12):1006-13.
Score: 0.071
-
Development of subsquamous cancer after hybrid endoscopic therapy for intramucosal Barrett's cancer. Endoscopy. 2012; 44 Suppl 2 UCTN:E390-1.
Score: 0.066
-
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug; 143(2):336-46.
Score: 0.064
-
Upregulation of glycogen synthase kinase 3ß in human colorectal adenocarcinomas correlates with accumulation of CTNNB1. Clin Colorectal Cancer. 2011 Mar 01; 10(1):30-6.
Score: 0.059
-
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis. 2010 Aug; 16(8):1352-6.
Score: 0.056
-
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92.
Score: 0.053
-
Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):159-64.
Score: 0.047
-
Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy. 2007 Dec; 39(12):1086-91.
Score: 0.046
-
A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res. 2007 Oct; 142(2):239-45.
Score: 0.045
-
Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin? Surgery. 2005 Oct; 138(4):658-63; discussion 663-4.
Score: 0.040
-
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 2005 Apr 15; 65(8):3146-54.
Score: 0.039
-
Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol. 2002 Jan; 97(1):27-31.
Score: 0.031
-
Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001 Nov; 25(11):1380-7.
Score: 0.031
-
Ploidy as a prognostic feature in colonic adenocarcinoma. Arch Surg. 1996 Jun; 131(6):587-92.
Score: 0.021
-
Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse. Cancer. 1994 Dec 01; 74(11):2908-17.
Score: 0.019
-
Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery. 1994 Oct; 116(4):804-9; discussion 809-10.
Score: 0.019
-
Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. Am J Clin Pathol. 2005 Jul; 124(1):11-9.
Score: 0.010
-
Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Hum Pathol. 2000 Jun; 31(6):672-7.
Score: 0.007